Investors
Key press releases
Key upcoming events
Key corporate presentation
Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and on the Euronext Growth Paris (ticker: ALCLS).
Cellectis ADS (Nasdaq)
Ticker: CLLS
$27.7900
-2.3200 (-7.7051%)
- Prev. close
- 30.1100
- Volume
- 368,777
- High
- 29.5700
- Capitalization
- 1.181B
Cellectis (Euronext Growth Paris)
Ticker: ALCLS
€23.0500
-1.3000 (-5.3388%)
- Prev. close
- 24.3500
- Volume
- 82,422
- High
- 23.5000
- Capitalization
- 979.375M
Covering research analysts
Barclays - Gena Wang
Citi - Yigal Nochomovitz
Goldman Sachs - Salveen Richter
Guggenheim - Michael Schmidt
Jefferies – Biren Amin
Jones Trading - Soumit Roy
Kempen - Ingrid Gafanhão
Ladenburg – Wangzhi Li
Oddo BHF - Martial Descoutures
Oppenheimer – Hartaj Singh
Portzamparc – Christophe Dombu
RW Baird - Madhu Kumar
Wells Fargo – Jim Birchenough
William Blair – Raju Prasad
Cellectis contact information
Simon Harnest
Investor Relations USA
+1 646 385 9008
Citibank ADR contact information
Intermediaries & Investors
US: +1 212 723 5435
UK: +44 207 500 2030
Société Générale Securities Services - Ordinary Shares contact information
Call center in English and French
Monday to Friday from 8:30am to 6pm CEST
+33 (0)2 51 85 67 89